U.S. Metals and Mining Stock News

NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Baidu (NasdaqGS:BIDU) One Off C¥19.6b Loss Challenges Earnings Narrative

Baidu (NasdaqGS:BIDU) has wrapped up FY 2025 with fourth quarter revenue of C¥32.7b and basic EPS of C¥5.24, capping a year in which trailing twelve month revenue came in at C¥129.1b and basic EPS at C¥16.40. Over recent quarters the company has seen quarterly revenue move between C¥32.5b and C¥32.7b, while basic EPS has ranged from a loss of C¥33.12 in Q3 2025 to C¥22.44 in Q1 2025. This has occurred alongside a trailing net profit margin of 6.4% compared with 15.3% a year earlier, which...
NasdaqGS:ALEC
NasdaqGS:ALECBiotechs

Alector (ALEC) Posts Steep US$37 Million Quarterly Loss Testing Bullish Pipeline Narratives

Alector (ALEC) has laid out its FY 2025 story with fourth quarter revenue of US$6.2 million, a basic EPS loss of US$0.34 and net income loss of US$37.3 million, set against trailing 12 month revenue of US$21.0 million and a full year EPS loss of US$1.39 on a US$142.9 million net loss. Over recent quarters, the company has seen revenue move between US$3.3 million and US$7.9 million with basic EPS losses ranging from US$0.30 to US$0.41 per quarter, while the prior year fourth quarter showed...
NasdaqGM:RXST
NasdaqGM:RXSTMedical Equipment

RxSight (RXST) Loss Deepens In Q4 Results Reinforcing Bearish Profitability Narratives

RxSight (RXST) has just reported its FY 2025 numbers with Q4 revenue of US$32.6 million and a basic EPS loss of US$0.22, while on a trailing twelve month basis revenue was US$134.5 million and basic EPS was a loss of US$0.95, keeping the focus firmly on how quickly the business can scale toward profitability. Over the past few quarters, the company has seen revenue range from US$30.3 million to US$40.2 million and basic EPS losses move between US$0.15 and US$0.29, which puts a spotlight on...
NYSE:HCI
NYSE:HCIInsurance

HCI Group (HCI) Combined Ratio Improvement Reinforces Bullish Underwriting Narratives

HCI Group (HCI) has capped FY 2025 with fourth quarter revenue of US$246.2 million and basic EPS of US$7.50, rounding out a year where trailing twelve month revenue reached US$900.9 million and EPS came in at US$24.58. Over the past few quarters, the company has seen revenue move from US$161.9 million and EPS of roughly US$0.22 in Q4 2024 to US$216.4 million and EPS of US$6.47 in Q1 2025, US$221.9 million and EPS of US$6.08 in Q2, and US$216.4 million with EPS of about US$5.06 in Q3. This...
NYSE:QXO
NYSE:QXOTrade Distributors

QXO (QXO) Q4 Loss Narrows To US$90.2m Testing Bearish Profitability Narratives

QXO (QXO) has just reported its FY 2025 numbers, with Q4 revenue of US$2.2 billion and a basic EPS loss of US$0.13 per share on net income excluding extra items of a US$90.2 million loss. Over recent quarters the company has seen revenue move from US$13.5 million and EPS of US$0.03 loss in Q1 2025 to US$2.7 billion and EPS of US$0.24 loss in Q3 2025, before landing at US$2.2 billion and EPS of US$0.13 loss in Q4. Trailing twelve month revenue sits at US$6.8 billion and EPS at US$0.46 loss,...
NasdaqGS:CARL
NasdaqGS:CARLMedical Equipment

Carlsmed (CARL) Revenue Growth At 85.9% Tests Bearish Profitability Narratives

Carlsmed (CARL) has reported its FY 2025 fourth quarter with total revenue of US$15.2 million and a basic EPS loss of US$0.32, while on a trailing twelve month basis revenue was US$50.5 million and basic EPS was a loss of US$2.12. The company has seen quarterly revenue move from US$9.4 million in Q4 2024 to US$15.2 million in Q4 2025, as basic EPS shifted from a loss of US$1.14 to a loss of US$0.32 over the same period, setting up a story where faster top line expansion is still being weighed...
NasdaqGS:GDRX
NasdaqGS:GDRXHealthcare Services

GoodRx Holdings GDRX Margin Improvement Reinforces Bullish Profitability Narratives

GoodRx Holdings (GDRX) FY 2025 Earnings Snapshot GoodRx Holdings (GDRX) closed out FY 2025 with Q4 revenue of US$194.8 million and basic EPS of US$0.02. Trailing twelve month figures came in at US$796.9 million of revenue and EPS of US$0.09 on net income of US$30.4 million. The company has seen quarterly revenue move from US$198.6 million in Q4 2024 to a range of US$195.3 million to US$203.1 million through 2025, with EPS running between US$0.00 and US$0.04 across those same periods. With...
NYSE:AI
NYSE:AISoftware

C3.ai (AI) Q3 Loss Worsening To US$0.94 EPS Reinforces Bearish Profitability Concerns

C3.ai (AI) just posted its Q3 2026 numbers, with revenue of US$53.3 million and a basic EPS loss of US$0.94, while trailing twelve month revenue came in at US$307.4 million and EPS at a loss of US$3.17. Over the last six reported quarters, the company has seen quarterly revenue move from US$94.3 million in Q2 2025 to US$53.3 million in Q3 2026, with basic EPS losses ranging between US$0.52 and US$0.94. This sets up an earnings story that is centered on loss-making margins and the pace at...
NYSE:MIAX
NYSE:MIAXCapital Markets

Miami International Holdings Q4 Profit Rebound Tests Bullish Earnings Recovery Narrative

Miami International Holdings FY 2025 earnings snapshot Miami International Holdings (MIAX) has reported a mixed FY 2025 finish, with fourth quarter revenue of US$369.4 million and EPS of US$0.34. The trailing twelve months still reflect a loss of US$70.0 million on revenue of US$1.4 billion and a TTM EPS loss of US$0.82. In recent quarters the company’s quarterly revenue moved from US$323.9 million in Q4 2024 to US$369.4 million in Q4 2025, while EPS shifted from US$0.05 in Q4 2024 to US$0.34...
NasdaqGS:SFNC
NasdaqGS:SFNCBanks

Simmons First National (SFNC) Net Interest Margin Rebound Tests Bearish Profitability Narratives

Simmons First National (SFNC) closed out FY 2025 with fourth quarter revenue of US$233.9 million and basic EPS of US$0.54, following a turbulent year in which trailing twelve month figures show revenue of US$37.4 million and a basic EPS loss of US$2.96. Over recent quarters, the company has seen quarterly revenue move from US$162.7 million in Q3 2024 to US$195.2 million in Q4 2024, then to US$182.8 million, US$202.2 million and US$233.9 million through Q1 to Q4 2025. Basic EPS shifted from...
NasdaqGS:CHYM
NasdaqGS:CHYMDiversified Financial

Chime Financial (CHYM) Q2 Loss Of US$923m Fuels Bearish Profitability Narratives

Chime Financial (CHYM) closed out FY 2025 with Q4 revenue of US$596.4 million and a basic EPS loss of US$0.12. Trailing 12 month figures show revenue of about US$2.2 billion and a basic EPS loss of US$4.27, keeping the story firmly in loss-making territory. Over recent periods the company has seen revenue move from US$475.2 million in Q4 2024 to US$596.4 million in Q4 2025. This has come alongside quarterly EPS that has swung between a profit of US$0.20 in Q1 2025 and a loss of US$7.29 in Q2...
NasdaqGS:GERN
NasdaqGS:GERNBiotechs

Geron (GERN) Q4 Loss Of US$31.1 Million Tests Bullish Profitability Narrative

Geron (GERN) has just posted its FY 2025 results, with Q4 total revenue of US$48.0 million and a basic EPS loss of US$0.05, alongside trailing twelve month revenue of US$183.9 million and a TTM basic EPS loss of US$0.13. Over recent periods the company has seen quarterly revenue move between US$39.6 million and US$49.0 million, while basic EPS losses have ranged from US$0.02 to US$0.05 per quarter. This sets the backdrop for how investors assess the current TTM net loss of US$85.8 million and...
NYSE:A
NYSE:ALife Sciences

Agilent Technologies (A) Margin Slippage Challenges Bullish Earnings Improvement Narrative

Agilent Technologies (A) has opened fiscal Q1 2026 with revenue of US$1.8b and basic EPS of US$1.08, setting the tone against a trailing twelve month picture that shows US$7.1b in revenue and EPS of US$4.55. Over the past year, the company has seen quarterly revenue move from US$1.70b in Q4 2024 to US$1.86b in Q4 2025 and then to US$1.80b in Q1 2026. Basic EPS shifted from US$1.23 to US$1.53 and now US$1.08, leaving investors focused on how the 18.3% trailing net margin shapes the quality of...
NYSE:GMED
NYSE:GMEDMedical Equipment

Globus Medical (GMED) Net Margin Reset Tests Bullish Long Term Earnings Narratives

Globus Medical (GMED) just closed out FY 2025 with Q4 revenue of US$826.4 million and basic EPS of US$1.05. Trailing twelve month revenue reached about US$2.9 billion and EPS came in at US$3.98, setting the stage for a sharply different earnings profile compared with a year earlier. Over the past six quarters, the company has seen quarterly revenue move from US$625.7 million in Q3 2024 to US$826.4 million in Q4 2025, with basic EPS shifting from US$0.38 to US$1.05 across the same period. This...
NYSE:EE
NYSE:EEOil and Gas

Excelerate Energy Q4 Margin Compression Tests Bullish Growth Narrative

Excelerate Energy (EE) has wrapped up FY 2025 with fourth quarter revenue of US$317.6 million, basic EPS of US$0.29 and net income of US$9.1 million. Trailing twelve month revenue sits at about US$1.2 billion, with basic EPS of US$1.31 and net income of US$39.2 million. The company has seen quarterly revenue move from US$274.6 million in Q4 2024 to US$317.6 million in Q4 2025. EPS has run between US$0.15 and US$0.48 over the last four reported quarters. These headline numbers can be weighed...
NYSE:WTRG
NYSE:WTRGWater Utilities

Essential Utilities (WTRG) Margin Compression Challenges Long‑Running Earnings Growth Narrative

Essential Utilities (WTRG) has wrapped up FY 2025 with fourth quarter revenue of US$699.1 million and basic EPS of US$0.47, alongside trailing 12 month revenue of US$2.5 billion and EPS of US$2.20, setting a clear earnings picture for investors to work with. The company has seen revenue move from US$2.1 billion and EPS of US$2.17 on a trailing basis in Q4 2024 to US$2.5 billion and EPS of US$2.20 in Q4 2025, while quarterly revenue has shifted from US$604.4 million a year ago to US$699.1...
NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

Sarepta Therapeutics (SRPT) Q4 Loss Deepens And Tests Bullish Profitability Narrative

Sarepta Therapeutics (SRPT) closed out FY 2025 with Q4 revenue of US$442.9 million and a basic EPS loss of US$3.93, alongside a full year trailing net loss of US$713.4 million on US$2.2 billion of revenue. Over the last six quarters in the data, revenue has ranged from US$399.4 million to US$744.9 million per quarter. Basic EPS has swung between a profit of US$2.01 and a loss of US$4.60, highlighting sharp shifts in margins that keep profitability firmly in focus for investors. See our full...
NYSE:ZIP
NYSE:ZIPInteractive Media and Services

ZipRecruiter FY 2025 Loss Narrows To US$0.01 Per Share Testing Bearish Profitability Views

ZipRecruiter FY 2025 earnings snapshot ZipRecruiter (ZIP) has wrapped up FY 2025 with fourth quarter revenue of US$111.7 million and a basic EPS loss of US$0.01, setting the tone for a year where profitability stayed out of reach. Over recent periods, the company has seen quarterly revenue move from US$110.1 million in Q1 2025 to US$114.98 million in Q3 2025. Basic EPS losses ranged from US$0.13 in Q1 to US$0.11 in Q3 and US$0.01 in Q4, keeping margins under pressure. For investors, the focus...
NYSE:NLOP
NYSE:NLOPOffice REITs

Net Lease Office Properties FFO Loss In Q4 2025 Reinforces Bearish Narratives

Net Lease Office Properties (NLOP) just wrapped up FY 2025 with Q4 total revenue of US$30.7 million, Funds From Operations of a US$44.6 million loss, and basic EPS of a US$0.00 loss, alongside Q4 net income excluding extra items of essentially breakeven at a US$0.05 million loss. Over recent quarters, revenue has moved between US$27.7 million in Q4 2024 and US$30.7 million in Q4 2025, while quarterly EPS ranged from a profit of US$0.03 in Q1 2025 to a loss of US$5.50 in Q2 2025, underscoring...
NasdaqGS:ECPG
NasdaqGS:ECPGConsumer Finance

Encore Capital Group (ECPG) Earnings Rebound Tests Bearish Profitability Narratives

Encore Capital Group (ECPG) just closed FY 2025 with Q4 revenue of US$473.6 million and basic EPS of US$3.43, backed by net income of US$76.7 million for the quarter. The company has seen quarterly revenue move from US$265.6 million in Q4 2024 and US$367.1 million in Q3 2024 to US$392.8 million, US$442.1 million, US$460.4 million and now US$473.6 million across the four quarters of 2025, while EPS shifted from a loss of US$9.42 in Q4 2024 to positive prints of US$1.96, US$2.50, US$3.22 and...
NYSE:AUB
NYSE:AUBBanks

Atlantic Union Bankshares CFO Transition And What It May Mean For Valuation

Atlantic Union Bankshares (NYSE:AUB) has appointed Alexander D. Dodd as Chief Financial Officer. Dodd succeeds longtime CFO Robert M. Gorman, who served in the role for nearly 14 years. The company is planning a structured transition that includes an advisory period for Gorman. For investors watching Atlantic Union Bankshares at a share price of $39.51, a CFO transition of this kind is a meaningful leadership event. With Robert M. Gorman stepping aside after nearly 14 years and Alexander D...
NasdaqGS:ATEC
NasdaqGS:ATECMedical Equipment

Alphatec Holdings (ATEC) Quarterly Loss Narrowing Challenges Longstanding Bearish Profitability Narrative

Alphatec Holdings (ATEC) closed out FY 2025 with Q4 revenue of US$212.9 million and a basic EPS loss of US$0.14, alongside net income excluding extra items of a US$21.7 million loss, setting a clear snapshot of where the business stands on growth and profitability. The company has seen quarterly revenue move from US$150.7 million in Q3 2024 to US$196.5 million in Q3 2025, and then to US$212.9 million in Q4 2025. Basic EPS losses shifted from US$0.28 in Q3 2024 to US$0.19 in Q3 2025 and...
NasdaqGM:IRMD
NasdaqGM:IRMDMedical Equipment

Is It Too Late To Reassess IRADIMED (IRMD) After Its Strong Multi‑Year Share Price Run?

If you are wondering whether IRADIMED's current share price offers good value or is already pricing in a lot of optimism, you are in the right place. The stock last closed at US$100.50, with returns of 0.4% over 30 days, 5.2% year to date, 83.1% over 1 year, 170.0% over 3 years and 371.2% over 5 years. These figures may have changed how investors think about both its potential and its risks. Recent news coverage has focused on IRADIMED's position in medical technology and its role in...